EVREN TECHNOLOGIES, INC.
Newberry, FL · Founded 2018 · CIK 0001779895 · Medtech · Private
Transcutaneous auricular vagal nerve stimulation (taVNS) device for treating acute stress reactions
evrenvns.com →- Grants
- $430K
- 2 awards
- Sector median: 1
- Raised
- —
- 2 Form D · Oct 2023
- 35 months since last filing
- Contracts
- $172K
- 1 award · Defense
- #469 of 4531 in medtech
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Personalized tVNS device for research and treatment of PTSD | $256,581 | |
| Federal contract· 1 of 2 same day | Department of Defense · Medical Research And Development Purchase Order Army STTR Ph I Proposal No. A21C-T024-0283 Titled Transcutaneous Vagal Nerve Stimulation For Acute Stress Reactions. | $171,786 | |
| Federal grant· 2 of 2 same day | Department of Defense · Phase I · Transcutaneous Vagal Nerve Stimulation for Acute Stress Reactions | $172,993 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 466 | ANTA BIOTECHNOLOGIES CORPORATION | $174K | — |
| 467 | TWINSTRAND BIOSCIENCES INC | $174K | $85M |
| 468 | ISCIENCE INTERVENTIONAL CORP | $174K | $24M |
| 469 | EVREN TECHNOLOGIES, INC. | $172K | — |
| 470 | SPARK BIOMEDICAL INC. | $171K | $16M |
| 471 | Assurex Health | $171K | — |
| 472 | Gold Standard Diagnostics Corp. | $167K | $2.5M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Weaver GainesDirector · Executive Officer
Patents
- Ear Device And Paired Treatments Involving Nerve Stimulationapplication
- Ear Device And Paired Treatments Involving Nerve Stimulationapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.